Matthew Brams
Fondateur chez CINGULATE INC.
Fortune : 27 310 $ au 30/04/2024
Profil
Matthew N.
Brams is the founder of Cingulate Works, Inc. (2013) and Cingulate, Inc. (2013), where he holds the title of Chief Medical Officer & Executive Vice President.
Currently, he is a Clinical Associate Professor at Baylor College of Medicine.
Previously, he worked as the Medical Director & Principal at Bayou City Research, Inc. (1999-2021).
He received his undergraduate degree from The University of Texas at Austin and his doctorate from the University of Texas Health Science Center at Houston.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
CINGULATE, INC.
0,82% | 15/04/2024 | 32 512 ( 0,82% ) | 27 310 $ | 30/04/2024 |
Postes actifs de Matthew Brams
Sociétés | Poste | Début |
---|---|---|
CINGULATE INC. | Fondateur | 01/01/2013 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Fondateur | - |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Fondateur | 01/01/2013 |
Baylor College of Medicine | Corporate Officer/Principal | - |
Anciens postes connus de Matthew Brams
Sociétés | Poste | Fin |
---|---|---|
Bayou City Research, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Formation de Matthew Brams
The University of Texas at Austin | Undergraduate Degree |
University of Texas Health Science Center at Houston | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CINGULATE INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
Bayou City Research, Inc. |